Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
EXEL | EXELIXIS, INC. | Director | $768K | May 31, 2024 | ||
AKRO | Akero Therapeutics, Inc. | Director | Jun 8, 2024 | |||
IVVD | Invivyd, Inc. | Director | May 23, 2023 | |||
OPTN | OptiNose, Inc. | Director | Jun 6, 2024 | |||
XLO | Xilio Therapeutics, Inc. | Director | Jun 12, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|